Skip to section navigation
Skip to page content

RAND > Topics >

Antimicrobial Resistance

Featured

Commentary

Europe's Fight Against Antimicrobial Resistance

Nov 3, 2016

The EC's AMR Action Plan included measures to ensure antimicrobials are used more appropriately in both humans and animals and measures to stimulate R&D of new antibiotics. One area that was not sufficiently covered was the environment.
Report

The Economic Costs of Antimicrobial Resistance

Dec 11, 2014

More and more bacterial and viral infections are resistant to antimicrobial drugs. But no new classes of antibiotics have entered the market for more than 25 years. Researchers estimate that failing to address this issue will mean a lower world population in 2050 than expected and at least $2 trillion in lost global GDP.

Explore Antimicrobial Resistance

Journal Article

Journal Article

Isolation Precautions Use for Multidrug-Resistant Organism Infection in Nursing Homes

To examine factors associated with isolation precaution use in nursing home (NH) residents with multidrug-resistant organism (MDRO) infection.

Mar 28, 2017
Journal Article

Antibiotics Prescribed as Often During Telemedicine Appointments as In-Person Visits

Patients treated for acute respiratory infections by a doctor on a telephone or live video are as likely to be prescribed an antibiotic as those treated in person. However, patients treated virtually are more often prescribed a broad-spectrum antibiotic, which is concerning because overuse of the drugs increases costs and contributes to antibiotic resistance.

Mar 28, 2017
Brochure

Spotlight on 2016

Spotlight, RAND Europe's annual review, features ways that our objective research and analysis expanded perspectives in 2016 to provide policy and decision makers the evidence and facts during a year of highly charged political debates.

Feb 1, 2017
Journal Article

Journal Article

Evaluation of the Action Plan Against the Rising Threats from Antimicrobial Resistance

This report presents an evaluation of the European Commission's 'Communication to the European Parliament and the Council on the Action Plan against the Rising Threats from Antimicrobial Resistance.'

Nov 4, 2016
News Release

News Release

More Support for Individual Member States Is Needed to Tackle AMR in Europe

An evaluation of the European Commission's Action Plan against antimicrobial resistance (AMR) has shown that individual member states need more help with developing and implementing their own action plans. A one-size-fits-all approach is insufficient when dealing with the diverse challenges in each country.

Nov 3, 2016
Project

Evaluating the EC Action Plan Against Antimicrobial Resistance (AMR)

On behalf of the Directorate-General for Health and Food Safety of the European Commission (DG SANTE), RAND Europe is undertaking an evaluation of the EC Action Plan Against Antimicrobial Resistance (AMR).

Nov 3, 2016
Research Brief

Research Brief

Europe's plan to tackle antimicrobial resistance: The success stories and challenges

This brief presents a brief summary of findings from an evaluation of the European Commission's "Evaluation of the EC Action Plan against the rising threats from antimicrobial resistance."

Nov 3, 2016
Journal Article

Journal Article

Evaluation of the EC Action Plan Against the Rising Threats from Antimicrobial Resistance: Final Report

This report presents an evaluation of the European Commission's 'Communication to the European Parliament and the Council on the Action Plan against the Rising Threats from Antimicrobial Resistance.'

Nov 3, 2016
Journal Article

Journal Article

Evaluation of the EC Action Plan Against the Rising Threats from Antimicrobial Resistance: Final Report - Appendices

This set of appendices supplements the final report for the 'Evaluation of the EC Action Plan against the rising threats from antimicrobial resistance'.

Nov 3, 2016
Commentary

Why the UN General Assembly Session on AMR Matters

Many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in longer illnesses and more deaths. The fact that world leaders are using the UN as a forum for discussions about antimicrobial resistance is a promising move toward developing a coordinated global plan.

Sep 19, 2016
Commentary

European and American Efforts to Tackle AMR: Great Minds Think Alike (Almost Always)

The United States and the European Union are committed to tackling antimicrobial resistance. Their efforts share objectives around key areas for improvement, such as the stewardship of existing antimicrobials, surveillance of their use, and development of new antimicrobials.

Aug 19, 2016
Commentary

The Rio Olympics Are the Site of a Battle Against 'Super Bacteria'

Brazilian scientists detected drug-resistant bacteria growing off some of Rio de Janeiro's beaches, close to where it will host sailing and wind-surfing events, and in the lagoon where the rowing and canoeing events will take place.

Jul 29, 2016
Commentary

The Global Economic Costs of Antimicrobial Resistance

In addition to being a public health problem, antimicrobial resistance is also a major economic concern. It crosses sectoral boundaries, because resistant bugs can pass between animals and humans, and through food, agriculture, and the environment.

May 20, 2016
Commentary

The O'Neill Review: A Critical Step in Taking Global Action Against AMR

The O'Neill Review aims to increase global knowledge of antimicrobial resistance (AMR) and generate international consensus about the nature of the problem and the necessary steps to tackle it. A RAND Europe analysis of the potential economic costs of AMR contributed to the Review.

May 19, 2016
Project

RAND Europe Focus on Antimicrobial Resistance (AMR)

RAND Europe's research has provided evidence to support policy and decision making to address antimicrobial resistance (AMR).

May 16, 2016
Brochure

Spotlight on 2015

RAND Europe's annual review, Spotlight on 2015, illustrates how our work helps to improve people's lives through policymaking based on objective research and rigorous analysis.

Jan 26, 2016
Project

Advising the Development of Public Health Guidelines to Delay Antimicrobial Resistance

RAND Europe is reviewing the evidence of effectiveness, cost effectiveness, and related qualitative evidence relating to changing risk-related behaviours pertaining to antimicrobial use to inform the development of Department of Health/NICE guidelines aimed at delaying antimicrobial resistance.

Oct 1, 2015
Report

Antimicrobial stewardship: The effectiveness of educational interventions to change risk-related behaviours in the general population: A systematic review

A systematic review of the evidence of effectiveness and cost-effectiveness on changing the public's risk related behaviour pertaining to antimicrobial use to inform a NICE public health guideline aimed at delaying antimicrobial resistance.

Sep 30, 2015
Commentary

The Cost of Resistance and the Attack of the Microbes

If left unaddressed, the threat posed by antimicrobial resistance and the rise of “superbugs” could devastate the world economy and pose a deadly threat to humanity.

Aug 7, 2015

1
2
Next

RAND Topic:
Antimicrobial Resistance

Topic Synonyms:
AMR